Palmetto State News

Samaritan Biologics, a medical technology company, has announced an expansion of its operations in Greenville County. The $5 million investment is expected to create 85 new jobs. Founded in 2019, the company specializes in developing and distributing human amniotic allograft products for wound care and surgical applications.

The company will lease an 11,000-square-foot manufacturing facility at the Clemson University International Center for Automotive Research (CU-ICAR) campus located at 215 Innovation Drive in Greenville. This facility will feature five clean rooms dedicated to processing human cellular tissue products. Operations are anticipated to commence in January 2025.

The Coordinating Council for Economic Development has approved job development credits related to this project and awarded a $100,000 Set-Aside grant to Greenville County to aid with building improvement costs.

Jerry Chang, Samaritan Biologics COO and Managing Partner, commented on the region's appeal: “Samaritan Biologics recognizes that Greenville, S.C. has evolved into a region fueled by research, businesses, and a smart, young and creative workforce that both thrives on, and is a catalyst for innovation.” He added that the support from South Carolina and Greenville County would help bring transformative care to patients.

Governor Henry McMaster praised the investment: “Samaritan Biologics’ decision to invest $5 million and create 85 new jobs in Greenville County is great news for the Upstate.”

Secretary of Commerce Harry M. Lightsey III noted the importance of the life sciences sector: “As a fast-growing industry in our state, the life sciences sector continues to create opportunities for the people of South Carolina.”

Greenville County Council Chairman Dan Tripp emphasized the benefits of this investment: “Samaritan Biologics’ investment in Greenville County not only brings new jobs and capital investment but also strengthens our life sciences industry.”

Greenville Mayor Knox White highlighted local resources available to Samaritan Biologics: “With multiple robust healthcare systems... their location at CU-ICAR... will propel their efforts to develop the next generation of products.”

David Clayton from CU-ICAR expressed enthusiasm about welcoming Samaritan Biologics: “Clemson University is excited to welcome Samaritan Biologics... As a research campus dedicated to supporting technology-based economic development...”

Those interested in employment opportunities with Samaritan Biologics can send resumes via email.